• Je něco špatně v tomto záznamu ?

Drug-resistant hypertension in primary aldosteronism patients undergoing adrenal vein sampling: the AVIS-2-RH study

GP. Rossi, G. Rossitto, L. Amar, M. Azizi, A. Riester, M. Reincke, C. Degenhart, J. Widimsky, M. Naruse, J. Deinum, L. Schultze Kool, T. Kocjan, A. Negro, E. Rossi, G. Kline, A. Tanabe, F. Satoh, LC. Rump, O. Vonend, HS. Willenberg, PJ. Fuller,...

. 2022 ; 29 (2) : e85-e93. [pub] 20220311

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc22019196

AIMS: We aimed at determining the rate of drug-resistant arterial hypertension in patients with an unambiguous diagnosis of primary aldosteronism (PA). Moreover, we sought for investigating the diagnostic performance of adrenal vein sampling (AVS), and the effect of adrenalectomy on blood pressure (BP) and prior treatment resistance in PA patients subtyped by AVS in major referral centres. METHODS AND RESULTS: The Adrenal Vein Sampling International Study-2 (AVIS-2) was a multicentre international study that recruited consecutive PA patients submitted to AVS, according to current guidelines, during 15 years. The patients were over 18 years old with arterial hypertension and had an unambiguous diagnosis of PA. The rate of resistant hypertension was assessed at baseline and after adrenalectomy using the American Heart Association (AHA) 2018 definition. Information on presence or absence of resistant hypertension was available in 89% of the 1625 enrolled PA patients. Based on the AHA 2018 criteria, resistant hypertension was found in 20% of patients, of which about two-thirds (14%) were men and one-third (6%) women (χ2 = 17.1, P < 1*10-4) with a higher rate of RH in men than in women (23% vs. 15% P < 1*10-4). Of the 292 patients with resistant hypertension, 98 (34%) underwent unilateral AVS-guided adrenalectomy, which resolved BP resistance to antihypertensive treatment in all. CONCLUSIONS: (i) Resistant hypertension is a common presentation in patients seeking surgical cure of PA; (ii) AVS is key for the optimal management of patients with PA due to resistant hypertension; and (iii) AVS-guided adrenalectomy allowed resolution of treatment-resistant hypertension.

3rd Department of Medicine Charles University Prague General Hospital Prague Czech Republic

AP HP Hôpital Européen Georges Pompidou Hypertension Department and DMU CARTE F 75015 Paris France

Centre for Endocrinology and Metabolism Hudson Institute of Medical Research Clayton Victoria Australia

Clinical Research Institute of Endocrinology and Metabolic Diseases National Hospital Organization Kyoto Medical Center and Endocrine Center Ijinkai Takeda General Hospital Kyoto Japan

Department of Endocrinology Diabetes and Metabolic Diseases University Medical Centre Ljubljana Zaloska 7 1525 Ljubljana Slovenia

Department of Endocrinology University of St Petersburg Russia

Department of Internal Medicine Azienda Unità Sanitaria Locale IRCCS Arcispedale S Maria Nuova Hypertension Unit Reggio Emilia Italy

Department of Internal Medicine National Taiwan University Hospital Taipei Taiwan

Department of Internal Medicine Radboud University Nijmegen Nijmegen Netherlands

Department of Medicine DIMED Emergency and Hypertension Unit University of Padova University Hospital via Giustiniani 2 35126 Padova Italy

Department of Medicine Monash University Clayton Victoria Australia

Department of Nephrology Endocrinology and Vascular Medicine Tohoku University Hospital Sendai Japan

Department of Nephrology Medical Faculty Heinrich Heine University Düsseldorf Germany

Division of Endocrinology and Metabolism Rostock University Medical Center Ernst Heydemann Str 6 18057 Rostock Germany

Endocrinology in Charlottenburg Berlin Germany

Faculty of Medicine University of Ljubljana Vrazov trg 2 1000 Ljubljana Slovenia

Institute of Cardiovascular and Medical Sciences University of Glasgow Glasgow UK

Institute of Clinical Endocrinology Tokyo Women's Medical University Tokyo Japan

Medical College of Wisconsin Endocrinology Center North Hills Health Center Menomonee Falls WI 53051 USA

Medizinische Klinik und Poliklinik 4 Klinikum der Universität München LMU München München Germany

Nephrology Department Hypertension Unit Hospital del Mar Universitat Autònoma de Barcelona Barcelona Spain

Université de Paris INSERM CIC1418 and UMR 970 F 75015 Paris France

University of Calgary Foothills Medical Centre Calgary Canada

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22019196
003      
CZ-PrNML
005      
20220804135427.0
007      
ta
008      
220720s2022 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1093/eurjpc/zwaa108 $2 doi
035    __
$a (PubMed)33742213
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Rossi, Gian Paolo $u Department of Medicine-DIMED, Emergency and Hypertension Unit, University of Padova, University Hospital, via Giustiniani, 2, 35126 Padova, Italy
245    10
$a Drug-resistant hypertension in primary aldosteronism patients undergoing adrenal vein sampling: the AVIS-2-RH study / $c GP. Rossi, G. Rossitto, L. Amar, M. Azizi, A. Riester, M. Reincke, C. Degenhart, J. Widimsky, M. Naruse, J. Deinum, L. Schultze Kool, T. Kocjan, A. Negro, E. Rossi, G. Kline, A. Tanabe, F. Satoh, LC. Rump, O. Vonend, HS. Willenberg, PJ. Fuller, J. Yang, NYN. Chee, SB. Margill, Z. Shafigullina, M. Quinkler, A. Oliveras, BC. Lee, VC. Wu, Z. Kratka, TM. Seccia, L. Lenzini
520    9_
$a AIMS: We aimed at determining the rate of drug-resistant arterial hypertension in patients with an unambiguous diagnosis of primary aldosteronism (PA). Moreover, we sought for investigating the diagnostic performance of adrenal vein sampling (AVS), and the effect of adrenalectomy on blood pressure (BP) and prior treatment resistance in PA patients subtyped by AVS in major referral centre $a AIMS We aimed at determining the rate of drug resistant arterial hypertension in patients with an unambiguous diagnosis of primary aldosteronism PA Moreover we sought for investigating the diagnostic performance of adrenal vein sampling AVS and the effect of adrenalectomy on blood pressure BP and prior treatment resistance in PA patients subtyped by AVS in major referral centres METHODS $a AIMS: We aimed at determining the rate of drug-resistant arterial hypertension in patients with an unambiguous diagnosis of primary aldosteronism (PA). Moreover, we sought for investigating the diagnostic performance of adrenal vein sampling (AVS), and the effect of adrenalectomy on blood pressure (BP) and prior treatment resistance in PA patients subtyped by AVS in major referral centres. METHODS AND RESULTS: The Adrenal Vein Sampling International Study-2 (AVIS-2) was a multicentre international study that recruited consecutive PA patients submitted to AVS, according to current guidelines, during 15 years. The patients were over 18 years old with arterial hypertension and had an unambiguous diagnosis of PA. The rate of resistant hypertension was assessed at baseline and after adrenalectomy using the American Heart Association (AHA) 2018 definition. Information on presence or absence of resistant hypertension was available in 89% of the 1625 enrolled PA patients. Based on the AHA 2018 criteria, resistant hypertension was found in 20% of patients, of which about two-thirds (14%) were men and one-third (6%) women (χ2 = 17.1, P < 1*10-4) with a higher rate of RH in men than in women (23% vs. 15% P < 1*10-4). Of the 292 patients with resistant hypertension, 98 (34%) underwent unilateral AVS-guided adrenalectomy, which resolved BP resistance to antihypertensive treatment in all. CONCLUSIONS: (i) Resistant hypertension is a common presentation in patients seeking surgical cure of PA; (ii) AVS is key for the optimal management of patients with PA due to resistant hypertension; and (iii) AVS-guided adrenalectomy allowed resolution of treatment-resistant hypertension.
650    _2
$a mladiství $7 D000293
650    _2
$a nadledviny $x krevní zásobení $x chirurgie $7 D000311
650    _2
$a adrenalektomie $x škodlivé účinky $x metody $7 D000315
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    12
$a hyperaldosteronismus $x diagnóza $x chirurgie $7 D006929
650    12
$a hypertenze $x diagnóza $x farmakoterapie $x epidemiologie $7 D006973
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a retrospektivní studie $7 D012189
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Rossitto, Giacomo $u Department of Medicine-DIMED, Emergency and Hypertension Unit, University of Padova, University Hospital, via Giustiniani, 2, 35126 Padova, Italy $u Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK $1 https://orcid.org/0000000190230835
700    1_
$a Amar, Laurence $u AP-HP, Hôpital Européen Georges-Pompidou, Hypertension Department and DMU CARTE, F-75015 Paris, France $u Université de Paris, INSERM, CIC1418 and UMR 970, F-75015 Paris, France $1 https://orcid.org/0000000339424276
700    1_
$a Azizi, Michel $u AP-HP, Hôpital Européen Georges-Pompidou, Hypertension Department and DMU CARTE, F-75015 Paris, France $u Université de Paris, INSERM, CIC1418 and UMR 970, F-75015 Paris, France
700    1_
$a Riester, Anna $u Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, LMU München, München, Germany $1 https://orcid.org/0000000332317435
700    1_
$a Reincke, Martin $u Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, LMU München, München, Germany $1 https://orcid.org/0000000298179875
700    1_
$a Degenhart, Christoph $u Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, LMU München, München, Germany
700    1_
$a Widimsky, Jiri $u 3rd Department of Medicine, Charles University Prague, General Hospital, Prague, Czech Republic $1 https://orcid.org/0000000182429705 $7 jn99240001422
700    1_
$a Naruse, Mitsuhide $u Clinical Research Institute of Endocrinology and Metabolic Diseases, National Hospital Organization Kyoto Medical Center and Endocrine Center, Ijinkai Takeda General Hospital, Kyoto, Japan $1 https://orcid.org/0000000289774090
700    1_
$a Deinum, Jaap $u Department of Internal Medicine, Radboud University Nijmegen, Nijmegen, Netherlands $1 https://orcid.org/0000000324651986
700    1_
$a Schultze Kool, Leo $u Department of Internal Medicine, Radboud University Nijmegen, Nijmegen, Netherlands
700    1_
$a Kocjan, Tomaz $u Department of Endocrinology, Diabetes and Metabolic Diseases, University Medical Centre Ljubljana, Zaloska 7, 1525 Ljubljana, Slovenia $u Faculty of Medicine, University of Ljubljana, Vrazov trg 2, 1000 Ljubljana. Slovenia $1 https://orcid.org/0000000186066825
700    1_
$a Negro, Aurelio $u Department of Internal Medicine, Azienda Unità Sanitaria Locale, IRCCS Arcispedale S. Maria Nuova, Hypertension Unit, Reggio Emilia, Italy
700    1_
$a Rossi, Ermanno $u Department of Internal Medicine, Azienda Unità Sanitaria Locale, IRCCS Arcispedale S. Maria Nuova, Hypertension Unit, Reggio Emilia, Italy
700    1_
$a Kline, Gregory $u University of Calgary, Foothills Medical Centre, Calgary, Canada
700    1_
$a Tanabe, Akiyo $u Institute of Clinical Endocrinology, Tokyo Women's Medical University, Tokyo, Japan $1 https://orcid.org/0000000256824952
700    1_
$a Satoh, Fumitoshi $u Department of Nephrology, Endocrinology and Vascular Medicine, Tohoku University Hospital, Sendai, Japan
700    1_
$a Rump, Lars Christian $u Department of Nephrology, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany
700    1_
$a Vonend, Oliver $u Department of Nephrology, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany $u Division of Endocrinology and Metabolism Rostock University Medical Center Ernst-Heydemann-Str. 6 18057 Rostock, Germany
700    1_
$a Willenberg, Holger S $u Division of Endocrinology and Metabolism Rostock University Medical Center Ernst-Heydemann-Str. 6 18057 Rostock, Germany
700    1_
$a Fuller, Peter J $u Centre for Endocrinology and Metabolism, Hudson Institute of Medical Research, Clayton, Victoria, Australia
700    1_
$a Yang, Jun $u Centre for Endocrinology and Metabolism, Hudson Institute of Medical Research, Clayton, Victoria, Australia $u Department of Medicine, Monash University, Clayton, Victoria, Australia $1 https://orcid.org/0000000346204976
700    1_
$a Chee, Nicholas Yong Nian $u Centre for Endocrinology and Metabolism, Hudson Institute of Medical Research, Clayton, Victoria, Australia $1 https://orcid.org/0000000295984908
700    1_
$a Margill, Steven B $u Medical College of Wisconsin, Endocrinology Center, North Hills Health Center, Menomonee Falls, WI 53051, USA $1 https://orcid.org/0000000173331239
700    1_
$a Shafigullina, Zulfiya $u Department of Endocrinology, University of St, Petersburg, Russia
700    1_
$a Quinkler, Marcus $u Endocrinology in Charlottenburg, Berlin, Germany $1 https://orcid.org/0000000340281671
700    1_
$a Oliveras, Anna $u Nephrology Department, Hypertension Unit, Hospital del Mar Universitat Autònoma de Barcelona, Barcelona, Spain
700    1_
$a Lee, Bo-Ching $u Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
700    1_
$a Wu, Vin Cent $u Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan $1 https://orcid.org/0000000179350991
700    1_
$a Kratka, Zuzana $u 3rd Department of Medicine, Charles University Prague, General Hospital, Prague, Czech Republic
700    1_
$a Seccia, Teresa M $u Department of Medicine-DIMED, Emergency and Hypertension Unit, University of Padova, University Hospital, via Giustiniani, 2, 35126 Padova, Italy $1 https://orcid.org/0000000236394086
700    1_
$a Lenzini, Livia $u Department of Medicine-DIMED, Emergency and Hypertension Unit, University of Padova, University Hospital, via Giustiniani, 2, 35126 Padova, Italy $1 https://orcid.org/0000000161463015
773    0_
$w MED00188754 $t European journal of preventive cardiology $x 2047-4881 $g Roč. 29, č. 2 (2022), s. e85-e93
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33742213 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220720 $b ABA008
991    __
$a 20220804135420 $b ABA008
999    __
$a ok $b bmc $g 1822688 $s 1170439
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 29 $c 2 $d e85-e93 $e 20220311 $i 2047-4881 $m European journal of preventive cardiology $n Eur J Prev Cardiol $x MED00188754
LZP    __
$a Pubmed-20220720

Najít záznam

Citační ukazatele

Možnosti archivace